System Status Mobile

SYSTEM STATUS MOBILE

Time	Market	Status
20:21:14 ET	NASDAQ BX Post - Trade PSX NASDAQ Options PHLX	Systems are operating normally

Time	Market	Status
20:21:14 ET	NASDAQ BX PSX NASDAQ Options	There are no messages available

Time	Market	Status
11:56:21 ET	NASDAQ	IPO Notice Update: The initial public offering of Mirum Pharmaceuticals, Inc. (MIRM) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
11:51:39 ET	NASDAQ	IPO Notice Update: The initial public offering of Mirum Pharmaceuticals, Inc. (MIRM) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
11:46:05 ET	NASDAQ	IPO Notice Update: The initial public offering of Mirum Pharmaceuticals, Inc. (MIRM) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
11:41:30 ET	NASDAQ	IPO Notice Update: The initial public offering of Mirum Pharmaceuticals, Inc. (MIRM) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
11:30:04 ET	NASDAQ	IPO Notice Update: The initial public offering of security, Pioneer Bancorp, Inc. (PBFS) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
11:25:01 ET	NASDAQ	IPO Notice Update: The initial public offering of security, Pioneer Bancorp, Inc. (PBFS) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
11:20:41 ET	NASDAQ	IPO Notice Update: The initial public offering of security, Pioneer Bancorp, Inc. (PBFS) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
11:15:03 ET	NASDAQ	IPO Notice Update: The initial public offering of security, Pioneer Bancorp, Inc. (PBFS) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
11:10:01 ET	NASDAQ	IPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
11:05:02 ET	NASDAQ	IPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
11:00:01 ET	NASDAQ	IPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
10:55:21 ET	NASDAQ	IPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
10:50:00 ET	NASDAQ	IPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
10:45:01 ET	NASDAQ	IPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
10:40:11 ET	NASDAQ	IPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
10:40:10 ET	NASDAQ	IPO Notice Update: The initial public offering of Genmab A/S American Depositary Shares (GMAB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
10:35:14 ET	NASDAQ	IPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
10:30:58 ET	NASDAQ	IPO Notice Update: The initial public offering of Genmab A/S American Depositary Shares (GMAB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
10:30:01 ET	NASDAQ	IPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
10:25:17 ET	NASDAQ	IPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
10:20:54 ET	NASDAQ	IPO Notice Update: The initial public offering of Genmab A/S American Depositary Shares (GMAB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
10:10:21 ET	NASDAQ	IPO Notice Update: The initial public offering of Genmab A/S American Depositary Shares (GMAB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.
09:12:19 ET	NASDAQ	IPO Notice: The initial public offering of Mirum Pharmaceuticals, Inc. (MIRM) will be released on Nasdaq today for quotation at 11:25 a.m. ET and will be eligible for trading at approximately 11:35 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.
09:00:19 ET	NASDAQ	IPO Notice: The initial public offering of Pioneer Bancorp, Inc. (PBFS) will be released on Nasdaq today for quotation at 11:00 a.m. ET and will be eligible for trading at approximately 11:10 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.
08:50:20 ET	NASDAQ	IPO Notice: The initial public offering of Fulcrum Therapeutics, Inc. (FULC) will be released on Nasdaq today for quotation at 10:10 a.m. ET and will be eligible for trading at approximately 10:20 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.
08:27:43 ET	NASDAQ	IPO Notice: The initial public offering of Conyers Park II Acquisition Corp. Units (CPAAU) will be released on Nasdaq today for quotation at 10:35 a.m. ET and will be eligible for trading at approximately 10:45 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.
08:03:31 ET	NASDAQ	IPO Notice: The initial public offering of Genmab A/S American Depositary Shares (GMAB) will be released on Nasdaq today for quotation at 09:50 a.m. ET and will be eligible for trading at approximately 10:00 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.

Time	Market	Status
20:21:14 ET	NASDAQ BX PSX NASDAQ Options	There are no messages available